Verastem Inc (VSTM)
11.84
+0.02
(+0.17%)
USD |
NASDAQ |
Mar 28, 16:00
11.85
+0.01
(+0.08%)
After-Hours: 20:00
Verastem Cash from Investing (TTM): -44.45M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -44.45M |
September 30, 2023 | -43.86M |
June 30, 2023 | 30.87M |
March 31, 2023 | 46.12M |
December 31, 2022 | 66.18M |
September 30, 2022 | 53.23M |
June 30, 2022 | 58.58M |
March 31, 2022 | 31.72M |
December 31, 2021 | 0.087M |
September 30, 2021 | -79.36M |
June 30, 2021 | -89.36M |
March 31, 2021 | -91.78M |
December 31, 2020 | -47.36M |
September 30, 2020 | 57.14M |
June 30, 2020 | 74.74M |
March 31, 2020 | 121.30M |
December 31, 2019 | 89.61M |
September 30, 2019 | -62.32M |
June 30, 2019 | -95.39M |
March 31, 2019 | -142.45M |
December 31, 2018 | -138.38M |
September 30, 2018 | -7.065M |
June 30, 2018 | 29.74M |
March 31, 2018 | 44.29M |
December 31, 2017 | 43.95M |
Date | Value |
---|---|
September 30, 2017 | 40.43M |
June 30, 2017 | 22.83M |
March 31, 2017 | 39.92M |
December 31, 2016 | 36.93M |
September 30, 2016 | 51.13M |
June 30, 2016 | 43.61M |
March 31, 2016 | 21.45M |
December 31, 2015 | -27.06M |
September 30, 2015 | -28.77M |
June 30, 2015 | -17.36M |
March 31, 2015 | -8.377M |
December 31, 2014 | 43.14M |
September 30, 2014 | 32.45M |
June 30, 2014 | -18.59M |
March 31, 2014 | -44.53M |
December 31, 2013 | -23.39M |
September 30, 2013 | -21.29M |
June 30, 2013 | 24.24M |
March 31, 2013 | 27.58M |
December 31, 2012 | -45.86M |
September 30, 2012 | -86.63M |
June 30, 2012 | -89.11M |
March 31, 2012 | -84.91M |
December 31, 2011 | -36.72M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-142.45M
Minimum
Mar 2019
121.30M
Maximum
Mar 2020
-3.337M
Average
15.48M
Median
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Geron Corp | -180.32M |
Cormedix Inc | -17.06M |
Karyopharm Therapeutics Inc | 7.94M |
AEON Biopharma Inc | -- |